COVAXIN to Begin Trials on Children Aged 2-18 Years
Indian Council of Medical Research and Bharat Biotech’s COVAXIN will kick-start phase II/III trials on children aged 2 to 18 years, NITI Aayog’s Dr. VK Paul said on Tuesday, adding that the process will commence in another 10 to 12 days.…
Read More...
Read More...